Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model

Background: Funding for neglected disease product development fell from 2009-2015, other than a brief injection of Ebola funding. One impediment to mobilizing resources is a lack of information on product candidates, the estimated costs to move them through the pipeline, and the likelihood of specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Ruth, Bekele, Tewodros, Gunn, Alexander, Chapman, Nick, Chowdhary, Vipul, Corrigan, Kelsey, Dahora, Lindsay, Martinez, Sebastián, Permar, Sallie, Persson, Johan, Rodriguez, Bill, Schäferhoff, Marco, Schulman, Kevin, Singh, Tulika, Terry, Robert F, Yamey, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139384/
https://www.ncbi.nlm.nih.gov/pubmed/30234193
http://dx.doi.org/10.12688/gatesopenres.12817.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139384/
https://www.ncbi.nlm.nih.gov/pubmed/30234193
http://dx.doi.org/10.12688/gatesopenres.12817.3

Ejemplares similares